Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Meter: A Multi-Country, Real-World Chart Review Study to Explore Treatment Patterns, Effectiveness and Healthcare Resource Utilization for Patients with Myelofibrosis

Vikas Gupta, Ciprian Tomuleasa, Gilberto Israel Barranco Lampon, Hsin-An Hou, Grzegorz Helbig, Argiris S. Symeonidis, Ibrahim Haznedaroglu, Kenny Galvez, Fernando Tatsch, Avijeet S Chopra, Meng Zhang, Tamas Vizkelety, David M Ross

Blood (2023) 142 (Supplement 1): 3205.

https://doi.org/10.1182/blood-2023-173942

Published: 2023

Journal Articles

Somatic Mutations and DNA Hypermethylation at Enhancers and Promoters Identify Distinct Subtypes within Lower-Risk Myelodysplastic Syndromes

Blood (2023) 142 (Supplement 1): 4587.

https://doi.org/10.1182/blood-2023-180071

Published: 2023

Journal Articles

Methylation Patterns of Fetal Hemoglobin Regulating Genes in High-Risk (HR) -MDS Patients Following Treatment with Azacytidine

Theodora Chatzilygeroudi, Vasiliki Chondrou, Katerina Athanasopoulou, Spyridon Alexis, Evgenia Verigou, Argyro Sgourou, Argiris S. Symeonidis

Blood (2023) 142 (Supplement 1): 6452.

https://doi.org/10.1182/blood-2023-187120

Published: 2023

Journal Articles

Bone Marrow Levels of PARP1 mRNA Predict Response to Treatment with 5-Azacytidine in Patients with Myelodysplastic Syndrome

Panagiotis Theodorou Diamantopoulos, MD PhD, Elina Kodandreopoulou, Argiris S. Symeonidis, Ioannis Kotsianidis, MDPhD, Vassiliki Pappa, MDPhD, Athanasios Galanopoulos, MD PhD, Maria Dimou, Georgia Christopoulou, Konstantinos Zervakis, Elena E. Solomou, MD PhD, Marie-Christine Kyrtsonis, MD PhD, Niki Rougala, Marina Siakantaris, MD, Theodoros Vassilakopoulos, MDPhD, Panayiotis Panayiotidis, MDPhD, Nora-Athina Viniou

Blood (2017) 130 (Supplement 1): 161.

https://doi.org/10.1182/blood.V130.Suppl_1.161.161

Published: 2017

Journal Articles

Ruxolitinib Remains Effective in Myelofibrosis after the Necessary Dose Reductions: Real-Life Data from a Multi-Center Observational Study

Blood (2016) 128 (22): 5476.

https://doi.org/10.1182/blood.V128.22.5476.5476

Published: 2016

Journal Articles

Validation of the Revised International Prognostic Scoring System in 2582 Patients with Myelodysplastic Syndrome: A Multicenter Study By the Hellenic MDS Study Group

Athanasios Galanopoulos, MD PhD, Christos K. Kontos, Nora-Athina Viniou, MD PhD, Ioannis Kotsianidis, MD PhD, Vassiliki Pappa, MD PhD, Aleka Kourakli, MD PhD, Anastasia Pouli, Panayiotis Panayiotidis, MD PhD, Paraskevi Roussou, MD PhD, Kalliopi Zafeiropoulou, Stamatis Karakatsanis, Maria Dimou, Anna Vardi, Theodoros Vassilakopoulos, MD PhD, Dimitris Tsokanas, Eleftheria Hatzimichael, MD PhD, Aikaterini Megalakaki, MD, Georgia D Kaiafa, MD PhD, Menelaos Konstantinos Papoutselis, Anastasia Sioni, Nikolaos Charchalakis, MD PhD, Eleni Bouronikou, MD PhD, George Vassilopoulos, MD PhD, Vasilios Lazaris, Maria Spiliotopoulou, Panagiotis Theodorou Diamantopoulos, Flora Kontopidou, MD PhD, Zoi Topouzoglou, Stamatina Kalyva, Helen A. Papadaki, MD PhD, Apostolos I Hatzitolios, Professor of Internal MDcine, Achilles Anagnostopoulos, MD, Evangelos Briasoulis, MD PhD, Nikolaos I. Anagnostopoulos, MD, Argiris S. Symeonidis, MD PhD

Blood (2016) 128 (22): 2004.

https://doi.org/10.1182/blood.V128.22.2004.2004

Published: 2016

Journal Articles

Greek Registry of Myelofibrosis: Baseline Characteristics and Therapeutic Strategy

Blood (2014) 124 (21): 5557.

https://doi.org/10.1182/blood.V124.21.5557.5557

Published: 2014

Journal Articles

Multiple Myeloma Patients ≤40 Years Of Age: Clinical Characteristics and Outcome In The Era Of Novel Agents

Argiris S. Symeonidis, Efstathios Kastritis, Sosana Delimpasi, Charikleia Kelaidi, Anastasia Sioni, Michalis Michael, Amalia Vassou, Anna Christoforidou, Panagiotis Repousis, Eudokia M. Mandala, Evangelos Terpos, Meletios A. Dimopoulos, MD

Blood (2013) 122 (21): 3226.

https://doi.org/10.1182/blood.V122.21.3226.3226

Published: 2013

Journal Articles

Preserved Levels Of Uninvolved Immunoglobulins Are Associated With Better Overall Survival In Patients With Multiple Myeloma Independently Of Disease Burden: A Role For The Immune System?

Blood (2013) 122 (21): 1866.

https://doi.org/10.1182/blood.V122.21.1866.1866

Published: 2013

Journal Articles

Estimated Glomerular Filtration Rate Calculated By The CKD-EPI Formula Has Improved Prognostic Ability Over MDRD Formula In Patients With Newly Diagnosed, Symptomatic, Multiple Myeloma: Analysis In 1937 Patients

Meletios A. Dimopoulos, MD, Evangelos Terpos, Argiris S. Symeonidis, Eirini Katodritou, Anastasia Pouli, Sosana Delimpasi, Kostas Konstantopoulos, Michalis Michael, Eleftheria Hatzimichael, Maria Kotsopoulou, Dimitra Gika, Maria Roussou, Stavroula Giannouli, Costas Tsatalas, Efstathios Kastritis

Blood (2013) 122 (21): 1867.

https://doi.org/10.1182/blood.V122.21.1867.1867

Published: 2013

Journal Articles

IgD Myeloma: Clinical Features and Outcome In The Era Of Novel Agents

Flora Zagouri, Efstathios Kastritis, Argiris S. Symeonidis, Nikolaos Giannakoulas, Eirini Katodritou, Sosana Delimpasi, Panagiotis Repousis, Stavroula Giannouli, Eudokia M. Mandala, Evangelos Terpos, Meletios A. Dimopoulos, MD

Blood (2013) 122 (21): 1935.

https://doi.org/10.1182/blood.V122.21.1935.1935

Published: 2013

Journal Articles

Clinical Features, Outcome and Prognostic Factors For Survival and Evolution To Multiple Myeloma Of Solitary Plasmacytomas: A Report Of The Greek Myeloma Study Group In 97 Patients

Blood (2013) 122 (21): 3130.

https://doi.org/10.1182/blood.V122.21.3130.3130

Published: 2013

Journal Articles

Competing Risk Survival Analysis In Patients With Symptomatic Waldenström’s Macroglobulinemia (WM): Disease Unrelated Mortality Accounts For Differences In Survival In Patients >75 Years

Efstathios Kastritis, Marie-Christine Kyrtsonis, MD, Evdoxia Hatjiharissi, Argiris S. Symeonidis, Amalia Vassou, Panagiotis Repousis, Sosana Delimpasi, Anastasia Sioni, Eurydiki Michalis, Michalis Michael, Elina Vervessou, Ekaterini Stefanoudaki, Michael Voulgarelis, Costas Tsatalas, Evangelos Terpos, Meletios A. Dimopoulos, MD

Blood (2013) 122 (21): 3197.

https://doi.org/10.1182/blood.V122.21.3197.3197

Published: 2013

Journal Articles

Hesk Ratio: A Complementary Tool for the Diagnosis of Myelodysplastic Syndromes and a Novel Method for Flow Cytometry Analysis

Evgenia Verigou, Georgia Kolliopoulou, Nikoleta Smirni, Elisavet Hala, Polixeni Lampropoulou, Sophia Mouzopoulou, Eirini Konstantinidou, Foteini Kalogianni, Panagiotis Zikos, Ioannis Starakis, Elena E. Solomou, Argiris S Symeonidis, Marina Karakantza

Blood (2012) 120 (21): 4946.

https://doi.org/10.1182/blood.V120.21.4946.4946

Published: 2012

Journal Articles

Impaired T-Lymphocyte Subpopulations and Deranged Profile of Immunologic Activation in Patients with Gaucher Disease Type I

Argiris S Symeonidis, George Theodorou, Constantina Repa, Theodore Marinakis, Panayiotis Tsaftaridis, Alexandra Kouraklis, Marina Karakantza, Nicholas Zoumbos

Blood (2008) 112 (11): 4915.

https://doi.org/10.1182/blood.V112.11.4915.4915

Published: 2008

NARROW

Meter: A Multi-Country, Real-World Chart Review Study to Explore Treatment Patterns, Effectiveness and Healthcare Resource Utilization for Patients with Myelofibrosis

Somatic Mutations and DNA Hypermethylation at Enhancers and Promoters Identify Distinct Subtypes within Lower-Risk Myelodysplastic Syndromes

Methylation Patterns of Fetal Hemoglobin Regulating Genes in High-Risk (HR) -MDS Patients Following Treatment with Azacytidine

Bone Marrow Levels of PARP1 mRNA Predict Response to Treatment with 5-Azacytidine in Patients with Myelodysplastic Syndrome

Ruxolitinib Remains Effective in Myelofibrosis after the Necessary Dose Reductions: Real-Life Data from a Multi-Center Observational Study

Validation of the Revised International Prognostic Scoring System in 2582 Patients with Myelodysplastic Syndrome: A Multicenter Study By the Hellenic MDS Study Group

Greek Registry of Myelofibrosis: Baseline Characteristics and Therapeutic Strategy

Multiple Myeloma Patients ≤40 Years Of Age: Clinical Characteristics and Outcome In The Era Of Novel Agents

Preserved Levels Of Uninvolved Immunoglobulins Are Associated With Better Overall Survival In Patients With Multiple Myeloma Independently Of Disease Burden: A Role For The Immune System?

Estimated Glomerular Filtration Rate Calculated By The CKD-EPI Formula Has Improved Prognostic Ability Over MDRD Formula In Patients With Newly Diagnosed, Symptomatic, Multiple Myeloma: Analysis In 1937 Patients

IgD Myeloma: Clinical Features and Outcome In The Era Of Novel Agents

Clinical Features, Outcome and Prognostic Factors For Survival and Evolution To Multiple Myeloma Of Solitary Plasmacytomas: A Report Of The Greek Myeloma Study Group In 97 Patients

Competing Risk Survival Analysis In Patients With Symptomatic Waldenström’s Macroglobulinemia (WM): Disease Unrelated Mortality Accounts For Differences In Survival In Patients >75 Years

Hesk Ratio: A Complementary Tool for the Diagnosis of Myelodysplastic Syndromes and a Novel Method for Flow Cytometry Analysis

Impaired T-Lymphocyte Subpopulations and Deranged Profile of Immunologic Activation in Patients with Gaucher Disease Type I

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only